We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Novel Food Application

6 Apr 2021 07:00

RNS Number : 4600U
Zoetic International PLC
06 April 2021
 

For immediate release

6 April 2021

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310

 

Zoetic International plc

('Zoetic', the 'Company' or the 'Group')

 

Zoetic's Novel Food Application passes FSA administrative check

 

Zoetic, the international CBD group, is pleased to provide the following update on its efforts to gain regulatory approval by the UK Food Standards Agency ('FSA' or the 'Agency') for its products in the United Kingdom. This FSA approval is now required for CBD products to be sold in the UK. This applies to all CBD brands and not only those owned by Zoetic.

 

Overview

· The FSA announced on 13 February 2020 that businesses must submit a novel food authorisation application by 31 March 2021 if they wish to have their CBD products sold in the UK. CBD products without the authorisation and subsequent validation would not be allowed to be sold in the UK.

 

· Zoetic submitted an application in conjunction with the European Industrial Hemp Association's ('EIHA') Novel Food Consortium.

 

· Zoetic received notification from EIHA that its CBD products passed the regulator's administrative check and can remain on sale in the UK.

 

· Official validation will be granted pending the results of toxicological studies on CBD, expected in the coming months.

 

Following the submission of a legal dossier, made in partnership with the EIHA's Novel Food Consortium, the Group has now received confirmation that its natural isolate CBD products can continue to be sold in the UK as the application has passed the regulator's administrative check. Official validation is expected to follow in the coming months, pending the results of toxicological studies of the CBD contained in its products.

 

Trevor Taylor, Co-CEO of Zoetic, said: "The FSA's regulation marks a pivotal moment for the CBD industry and Zoetic welcomes the Agency's efforts to protect consumers from CBD products that do not meet the necessary standards. We submitted our application with EIHA, a highly respected European industry association, and are thrilled that the submission has passed the initial check and we are now one step closer to full validation. As always, we are committed to rigorous quality assurance processes at every step because our success as a company is indivisible from the quality of our products."

 

Further progress is expected in the coming months. More information can be found on the EIHA website.

 

- Ends -

 

About the European Industrial Hemp Association

The European Industrial Hemp Association ('EIHA') represents the collective interests of key stakeholders in the hemp industry across the European Union ('EU'). Their primary function is to advocate for the industry by contributing to international policy-making consultations and decisions by European regulators. EIHA also operates a Novel Food Consortium which aims to secure the necessary regulatory approvals for members to continue producing and selling their products.

 

Publication on website

 

A copy of this announcement is also available on the Group's website at www.zoeticinternational.com

 

Media enquiries:

Zoetic International plc

c/o Buchanan

Trevor Taylor, Co-CEO

Antonio Russo, Co-CEO

 

 

Allenby Capital Limited (Financial Adviser and Broker)

+44 (0) 20 3328 5656

Nick Harriss (Corporate Finance)

 

Nick Naylor (Corporate Finance)

 

Guy McDougall (Equity Sales)

 

 

 

Buchanan

 

Henry Harrison-Topham / Jamie Hooper / Ariadna Peretz

Tel: +44 (0) 20 7466 5000

zoetic@buchanan.uk.com

www.buchanan.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKPBDDBKBKQK
Date   Source Headline
16th Aug 20217:00 amRNSChange of Name
3rd Aug 20214:00 pmRNSNotice of Results
30th Jul 20213:30 pmRNSHolding(s) in Company
29th Jul 20217:00 amRNSBusiness Update
8th Jul 20212:05 pmRNSSecond Price Monitoring Extn
8th Jul 20212:00 pmRNSPrice Monitoring Extension
1st Jul 20217:00 amRNSBusiness Update
7th Jun 20214:40 pmRNSSecond Price Monitoring Extn
7th Jun 20214:35 pmRNSPrice Monitoring Extension
1st Jun 20217:00 amRNSHolding(s) in Company
1st Jun 20217:00 amRNSIssue of Warrants
28th May 20215:00 pmRNSTotal Voting Rights
17th May 20217:00 amRNSUpdate on ‘Chill’ orders
4th May 20217:00 amRNSSubscription raises £6m, LDA financing cancelled
30th Apr 20215:00 pmRNSTotal Voting Rights
16th Apr 20217:00 amRNSTrading Update
12th Apr 20217:00 amRNSHolding(s) in Company
6th Apr 20217:00 amRNSNovel Food Application
31st Mar 20215:00 pmRNSTotal Voting Rights
31st Mar 20217:00 amRNSIssue of Shares
25th Mar 20217:00 amRNSExercise of Share Options
15th Mar 20212:30 pmRNSHolding(s) in Company
9th Mar 20219:06 amRNSSecond Price Monitoring Extn
9th Mar 20219:00 amRNSPrice Monitoring Extension
9th Mar 20217:00 amRNSFinancing Agreement with LDA Capital
8th Mar 20212:45 pmRNSHolding(s) in Company
2nd Mar 20213:00 pmRNSHolding(s) in Company
24th Feb 20217:00 amRNSUS Distribution Update
15th Feb 20217:00 amRNSProgress Update
3rd Feb 20219:05 amRNSSecond Price Monitoring Extn
3rd Feb 20219:00 amRNSPrice Monitoring Extension
28th Jan 20217:00 amRNSInterim Results
25th Jan 20214:40 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
8th Jan 20217:00 amRNSCommencement of trading on the OTCQX
31st Dec 20207:00 amRNSUpdate on Sale of DTU
22nd Dec 20204:36 pmRNSPrice Monitoring Extension
16th Dec 20202:05 pmRNSSecond Price Monitoring Extn
16th Dec 20202:00 pmRNSPrice Monitoring Extension
10th Dec 20206:00 pmRNSHolding(s) in Company
10th Dec 20206:00 pmRNSHolding(s) in Company
9th Dec 202010:00 amRNSHolding(s) in Company
8th Dec 202011:05 amRNSSecond Price Monitoring Extn
8th Dec 202011:00 amRNSPrice Monitoring Extension
8th Dec 20209:05 amRNSSecond Price Monitoring Extn
8th Dec 20209:00 amRNSPrice Monitoring Extension
30th Nov 20205:00 pmRNSTotal Voting Rights
27th Nov 202011:06 amRNSSecond Price Monitoring Extn
27th Nov 202011:00 amRNSPrice Monitoring Extension
24th Nov 20209:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.